A preliminary report on the effects of methanol extraction residue of BCG (MER) on cancer patients
- 1 July 1975
- journal article
- research article
- Published by Springer Nature in British Journal of Cancer
- Vol. 32 (1) , 1-4
- https://doi.org/10.1038/bjc.1975.126
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Chemoimmunotherapy of Disseminated Malignant Melanoma with Dimethyl Triazeno Imidazole Carboxamide and Bacillus Calmette-GuérinNew England Journal of Medicine, 1974
- BCG and CancerNew England Journal of Medicine, 1974
- BCG immunotherapy of rat tumors of defined immunogenicity.1973
- Immunotherapeutic studies in mice with the methanol-extraction residue (mer) fraction of BCG: solid tumors.1973
- Nonspecific stimulation and modulation of the immune response and of states of resistance by the methanol-extraction residue fraction of tubercle bacilli.1972
- Facilitation of Rat Mammary Tumour Growth by BCGNature, 1970
- Immunological factors which influence response to immunotherapy in malignant melanoma.1970
- ACTIVE IMMUNOTHERAPY FOR ACUTE LYMPHOBLASTIC LEUKÆMIAThe Lancet, 1969
- Effect of Bacillus Calmette-Guérin Infection on Transplanted Tumours in the MouseNature, 1959
- ANTITUBERCULOUS IMMUNITY INDUCED IN MICE BY VACCINATION WITH KILLED TUBERCLE BACILLI OR WITH A SOLUBLE BACILLARY EXTRACTThe Journal of Experimental Medicine, 1955